AIA Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-41,369
| Closed | -$2.32M | – | 346 |
|
|
2023
Q4 | $2.32M | Buy |
41,369
+365
| +0.9% | +$20.4K | 0.1% | 110 |
|
|
2023
Q3 | $1.69M | Buy |
41,004
+6,099
| +17% | +$252K | 0.08% | 113 |
|
|
2023
Q2 | $1.95M | Buy |
34,905
+11,010
| +46% | +$615K | 0.09% | 104 |
|
|
2023
Q1 | $1.33M | Buy |
23,895
+13,679
| +134% | +$763K | 0.07% | 122 |
|
|
2022
Q4 | $372K | Sell |
10,216
-7,450
| -42% | -$271K | 0.02% | 258 |
|
|
2022
Q3 | $503K | Buy |
17,666
+530
| +3% | +$15.1K | 0.03% | 190 |
|
|
2022
Q2 | $775K | Buy |
17,136
+1,976
| +13% | +$89.4K | 0.04% | 178 |
|
|
2022
Q1 | $1.15M | Sell |
15,160
-16,177
| -52% | -$1.23M | 0.05% | 156 |
|
|
2021
Q4 | $4.67M | Buy |
31,337
+9,053
| +41% | +$1.35M | 0.22% | 61 |
|
|
2021
Q3 | $3.24M | Buy |
22,284
+4,317
| +24% | +$628K | 0.18% | 73 |
|
|
2021
Q2 | $3.1M | Buy |
+17,967
| New | +$3.1M | 0.21% | 67 |
|